Onconova Therapeutics, Inc. (NASDAQ:ONTX) went higher by +3.44% to close at $ 3.61. The company exchanged total volume of 499.34 thousand shares throughout course of last trade however it holds an average trading capacity of 63.37 thousand shares. Shares of company began trading at $3.50 climbed to high of $3.69 touched the low of $3.28.
The company is trading below its 50-day moving averages of 4.40 and down from 200-day moving averages of 4.85. The firm has price to book ratio of 1.60 and its price to sale ratio was 0.75.
The average true range of Onconova Therapeutics, Inc.’s (ONTX) is recorded at 0.26 and the relative strength index of the stock stands 38.63. The stock price is going above to its 52 week low with 15.34% and lagging behind from its 52 week high with -90.98%. Analyst recommendation for this stock stands at 2.00. A look on the firm performance, its monthly performance is -24.95% and a quarterly performance of -27.80%. The stock price is trading downbeat from its 200 days moving average with -47.09% and down from 50 days moving average with -24.79%.
Idera Pharmaceuticals, Inc. (NASDAQ:IDRA) surged +2.58% and closed the trade at $ 1.99. The company recorded a trading capacity of 413.61 thousand shares below its three months average daily volume of 489.77 thousand shares. During the last trade, shares reached to high price of $2.00 and touched the low price of $1.90. The stock’s 50-day moving average is noted at $1.68 and its 200-day moving average is stands at $1.73.
Additionally, the company has EPS of -0.41. The company has market capitalization of $241.54M.
According to ZACKS data, different Brokerage Firms rated the stock about their BUY, SELL or HOLD recommendations. 1 Month Ago, shares have been suggested as “BUY” from “0” brokerage firms and recommended as “Strong Buy” by “3” brokerage firms. 0” brokerage firms have issued “Sell” rating for the company and “Strong Sell” rating was issued by “0” brokerage firms. “0” brokerage firms have rated the company as a “Hold”. The Corporation has average brokerage recommendation (ABR) of 1 based on consensus of the brokerage firms issuing ratings.
Idera Pharmaceuticals, Inc.’s (IDRA) has price-to-cash ratio of 3.83 and price to sale ratio of 294.37. A look on the firm performance, its monthly performance is 24.37% and a quarterly performance of 44.20%. The stock price is moving up from its 20 days moving average with 14.11% and isolated positively from 50 days moving average with 21.92%.